Eli Lilly and Company

Richard Walter Schevitz

Nicholas J Bach

Robert D Dillard

Susan Elizabeth Draheim

Robert B Hermann

Jason Scott Sawyer

Daniel Jon Sall

Douglas Wade Beight

John Michael Morin, Jr

Ho-Shen Lin

Jolie Anne Bastian

Michael Enrico Richett

Richard Waltz Harper

Michael LeRoy Phillips

Michael Dean Kinnick

Benjamin Alan Anderson

Edward David Mihelich

Tulio Suarez

Robert Theodore Vasileff

Michael Lyle Denney

Nancy Kay Harn

Gary A Hite

John Mcneill McGill, Iii

Richard James Loncharich

A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA mediated release of fatty acids for treatment of conditions such as septic shock.

Substituted tricyclics

A class of novel 1H-indole-3-acetamides is disclosed together with the use of such indole compounds for inhibiting sPLA,mediated release of fatty acids for treatment of conditions such as septic shock.

1H-indole-3-acetamide sPLA2 inhibitors

A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA,mediated release of fatty acids for treatment of conditions such as septic shock.

A class of novel 1-indole-3-acetamides represented by the formula; ##STR1## is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids.

1H-indole-3-acetamide sPLA.sub.2 inhibitors

A class of novel 1H-indole-3-acetic acid hydrazides is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids (e.g., arachidonic acid) for treatment of conditions such as septic shock.

1H-indole-3-acetic acid hydrazide sPLA.sub.2 inhibitors

Growing community of inventors

Indianapolis, IN, United States of America

Richard Walter Schevitz